Fresenius SE & Co. (OTCMKTS:FSNUY) Sets New 12-Month High - Should You Buy?

Key Points

• Fresenius SE & Co. shares reached a new 52-week high of $13.35 during trading, with a daily trading volume of 878 shares.
• Analysts at Morgan Stanley reaffirmed an "overweight" rating on Fresenius SE & Co., indicating positive sentiment towards the stock.
• The company reported a quarterly EPS of $0.24, exceeding estimates, and announced a dividend increase to $0.1827 per share, reflecting a solid financial performance.

Fresenius SE & Co. (OTCMKTS:FSNUY - Get Free Report)'s stock price hit a new 52-week high during trading on Wednesday . The company traded as high as $13.35 and last traded at $13.35, with a volume of 878 shares changing hands. The stock had previously closed at $12.99.

Analysts Set New Price Targets

Separately, Morgan Stanley reiterated an "overweight" rating on shares of Fresenius SE & Co. in a research report on Wednesday, August 13th.

Fresenius SE & Co. Trading Up 0.9%

The stock's 50 day simple moving average is $12.44 and its two-hundred day simple moving average is $11.54. The company has a debt-to-equity ratio of 0.50, a quick ratio of 1.11 and a current ratio of 1.43.

Fresenius SE & Co. (OTCMKTS:FSNUY - Get Free Report) last released its quarterly earnings data on Wednesday, August 6th. The company reported $0.24 EPS for the quarter, topping analysts' consensus estimates of $0.22 by $0.02. Fresenius SE & Co. had a return on equity of 9.33% and a net margin of 5.09%. The business had revenue of $6.48 billion during the quarter, compared to the consensus estimate of $5.83 billion. On average, equities analysts predict that Fresenius SE & Co. will post 0.79 earnings per share for the current fiscal year.

Fresenius SE & Co. Increases Dividend

The company also recently announced a dividend, which was paid on Wednesday, June 4th. Stockholders of record on Wednesday, May 28th were issued a dividend of $0.1827 per share. This represents a dividend yield of 148.0%. The ex-dividend date was Tuesday, May 27th. This is an increase from Fresenius SE & Co.'s previous dividend of $0.17. Fresenius SE & Co.'s dividend payout ratio (DPR) is presently 35.85%.

About Fresenius SE & Co.

Fresenius SE & Co KGaA, a health care company, provides products and services for chronically ill patients. It operates through four segments: Fresenius Medical Care, Fresenius Kabi, Fresenius Helios, and Fresenius Vamed. The Fresenius Medical Care segment offers products and services for patients with chronic kidney failure.